Legal Action and Market Reaction: Vital Farms Faces Investor Lawsuit

Vital Farms sued for allegedly downplaying ERP risks, causing operational disruptions, missed 2025 revenue targets, and an 11% stock drop. Analysts slash price targets.

Vital Farms, the ethical food company, is now confronting a significant legal challenge in the form of a class-action lawsuit, casting a shadow over investor confidence. The core allegation centers on the company's handling of a major IT system overhaul. Several U.S. law firms have filed suit, accusing Vital Farms of downplaying the substantial risks associated with implementing a new enterprise resource planning (ERP) system, thereby allegedly presenting a misleading financial outlook. The subsequent operational disruptions are cited as a direct cause for missed annual targets and a sharp decline in the company's share price.

Financial Fallout from Operational Disruptions

The tangible impact of these operational hurdles became clear with the release of Vital Farms' 2025 financial results. The company reported annual revenue of approximately $759 million, falling short of its own $775 million forecast. Earnings per share also disappointed the market, coming in at $0.35 against expectations of $0.39. The disclosure of these figures triggered an immediate sell-off, with the stock plummeting nearly eleven percent on the day of the announcement.

The lawsuit focuses on the period between May 2025 and February 2026. Plaintiffs argue that while company management discussed only hypothetical delays in risk disclosures, the real-world rollout led to significant disruptions in order fulfillment and production. This gap between disclosed risk and actual outcome forms the basis of the legal claim.

Analysts Downgrade and Market Sentiment Sours

The disappointing performance prompted a swift and severe reassessment from Wall Street analysts. Craig-Hallum drastically reduced its price target, citing intensified competition in the premium egg segment and volatile retail ordering patterns. Other firms followed suit with revised projections:

• Craig-Hallum: $20 (down from $55)
• Needham & Company: $20
• BMO Capital Markets: $50 (down from $60)

Concurrently, skepticism in the options market surged. Early April saw an extraordinary volume of put options traded—a spike of 110 percent above the average level. This activity indicates that traders are increasingly hedging against the potential for further share price declines, as the stock trades near its 52-week low.

For shareholders seeking to join the class-action proceedings, the deadline for participation is May 26, 2026. Looking forward, the company's priorities for the remainder of the 2026 fiscal year are clear: stabilizing the new ERP system and returning to volume-based growth.